Abstract

Ginsenosides (GS) as the main ingredient of ginseng, include dozens of monomer, such as Rg3, Rh2, Rd, Rh1, Rg2, etc. GS and various monomers have different anti-hepatoma mechanisms. The main mechanism includes the following aspects, inducing the apoptosis of liver cancer cells, inhibiting the proliferation, invasion and metastasis, reversing the multidrug resistance of liver cancer cells, increasing therapeutic effects by combining with other treatments, improving the immune function of organism and inhibiting hepatic glucose production. Different GS monomers play different roles of anti-hepatoma through their respective channels. Key words: Ginsenosides; Liver neoplasms; Pharmacology

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.